Small molecules in hematology

This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL...

Full description

Saved in:
Bibliographic Details
Other Authors: Martens, Uwe Marc (Editor)
Format: Book/Monograph
Language:English
Published: Cham, Switzerland Springer [2018]
Edition:Third edition
Series:Recent results in cancer research volume 212
In: Recent results in cancer research (volume 212)

Volumes / Articles: Show Volumes / Articles.
DOI:10.1007/978-3-319-91439-8
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/978-3-319-91439-8
Resolving-System, Volltext: http://dx.doi.org/10.1007/978-3-319-91439-8
Get full text
Author Notes:Uwe M. Martens, editor

MARC

LEADER 00000cam a2200000 c 4500
001 1030110891
003 DE-627
005 20250417182609.0
007 cr uuu---uuuuu
008 180903s2018 gw |||||o 00| ||eng c
020 |a 9783319914398  |9 978-3-319-91439-8 
024 7 |a 10.1007/978-3-319-91439-8  |2 doi 
035 |a (DE-627)1030110891 
035 |a (DE-576)510624774 
035 |a (DE-599)GBV1030110891 
035 |a (OCoLC)1056141056 
035 |a (DE-He213)978-3-319-91439-8 
035 |a (DE-627-1)040626202 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
044 |c XA-DE 
050 0 |a RB45 
060 0 |a  QZ 267 
072 7 |a MJF  |2 thema 
072 7 |a MJF  |2 bicssc 
072 7 |a MED038000  |2 bisacsh 
082 0 |a 616.15 
084 |a 33  |2 sdnb 
245 0 0 |a Small molecules in hematology  |c Uwe M. Martens, editor 
250 |a Third edition 
264 1 |a Cham, Switzerland  |b Springer  |c [2018] 
300 |a 1 Online-Ressource (VIII, 294 Seiten)  |b Illustrationen, Diagramme 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
490 1 |a Recent results in cancer research  |v volume 212 
490 0 |a SpringerLink  |a Bücher 
520 |a This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of precision cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title 
520 |a Imatinib -- Dasatinib -- Nilotinib -- Bosutinib -- Ponatinib -- Ruxolitinib -- Ibrutinib -- Lenalidomide -- Pomalidomide -- Enasidenib -- Midostaurin -- Alectinib -- Osimertinib -- Venetoclax -- Idelaslisib -- Carfilzomib -- Acalabrutinib 
533 |a Reproduktion  |f Springer eBook Collection. Medicine 
650 0 |a Oncology 
650 0 |a Hematology 
650 2 |a Neoplasms  |x drug therapy 
650 2 |a Antineoplastic Agents 
650 2 |a Hematologic Diseases 
650 2 |a Protein Kinase Inhibitors  |x therapeutic use 
700 1 |a Martens, Uwe Marc  |d 1966-  |e HerausgeberIn  |0 (DE-588)132250608  |0 (DE-627)519857070  |0 (DE-576)299031349  |4 edt 
776 1 |z 9783319914381 
776 1 |z 9783319914404 
776 0 8 |i Erscheint auch als  |t Small molecules in hematology  |b Third edition  |d Cham, Switzerland : Springer, 2018  |h viii, 294 Seiten  |w (DE-627)1641605863  |w (DE-576)510534279  |z 9783319914381 
830 0 |a Recent results in cancer research  |v volume 212  |9 212  |w (DE-627)548128227  |w (DE-576)9548128225  |w (DE-600)2393522-4  |x 2197-6767  |7 am 
856 4 0 |u https://doi.org/10.1007/978-3-319-91439-8  |m X:SPRINGER  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-91439-8  |x Resolving-System  |3 Volltext 
912 |a ZDB-2-SEB 
912 |a ZDB-2-SME  |b 2018 
912 |a ZDB-2-SXM  |b 2018 
935 |i Blocktest 
951 |a BO 
992 |a 20190411 
999 |a KXP-PPN1030110891  |e 3421421250 
BIB |a Y 
SPR |a Y 
JSO |a {"language":["eng"],"recId":"1030110891","physDesc":[{"noteIll":"Illustrationen, Diagramme","extent":"1 Online-Ressource (VIII, 294 Seiten)"}],"type":{"bibl":"edited-book","media":"Online-Ressource"},"relMultPart":[{"physDesc":[{"extent":"Online-Ressource"}],"dispAlt":"Recent results in cancer research","id":{"zdb":["2393522-4"],"eki":["548128227"],"issn":["2197-6767"]},"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisher":"Springer"}],"recId":"548128227","language":["eng"],"note":["Gesehen am 25.10.07"],"type":{"media":"Online-Ressource","bibl":"serial"},"disp":"Recent results in cancer research","part":{"number":["volume 212"],"number_sort":["212"]},"pubHistory":["Nachgewiesen 165.2006 -"],"title":[{"title_sort":"Recent results in cancer research","title":"Recent results in cancer research"}]}],"name":{"displayForm":["Uwe M. Martens, editor"]},"person":[{"given":"Uwe Marc","family":"Martens","role":"edt","display":"Martens, Uwe Marc","roleDisplay":"HerausgeberIn"}],"id":{"doi":["10.1007/978-3-319-91439-8"],"eki":["1030110891"],"isbn":["9783319914398"]},"origin":[{"publisher":"Springer","dateIssuedDisp":"[2018]","publisherPlace":"Cham, Switzerland","edition":"Third edition","editionNo":3,"dateIssuedKey":"2018"}],"title":[{"title":"Small molecules in hematology","title_sort":"Small molecules in hematology"}]} 
SRT |a SMALLMOLEC2018